Fractyl Health Says Revita Met Six-Month Co-Primary Endpoint
Revita retained about 80% of GLP-1-induced weight loss versus 67% for sham at six months (p=0.0023), Fractyl Health reported.
Fractyl Health reported Revita met the six-month co-primary endpoint, retaining ~80% of GLP-1—induced weight loss vs 67% for sham (p=0.0023).Key Highlights:Original SEC Filing: FRACTYL HEALTH, INC. [ GUTS ] - 8-K - Oct. 16, 2026This is an AI-powered summary. It may contain inaccuracies.
Consider ve…